Protective strategies to prevent trastuzumab-induced cardiotoxicity Reply

被引：0
|
作者：
Earl, Helena M. [1 ,2 ,3 ]
Hiller, Louise [4 ]
Plummer, Chris [6 ,7 ]
Miles, David [5 ]
Wardley, Andrew M. [9 ,10 ]
Cameron, David A. [8 ]
Dunn, Janet A. [4 ]
机构：
[1] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England
[2] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Cambridge Breast Canc Res Unit, Cambridge, England
[3] Cambridge Biomed Res Ctr, NIHR, Cambridge, England
[4] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England
[5] Mt Vernon Canc Ctr, Med Oncol, Northwood, Middx, England
[6] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England
[7] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[8] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Canc Edinburgh Res Ctr, Edinburgh, Midlothian, Scotland
[9] Christie NHS Fdn Trust, NIHR Manchester Clin Res Facil, Res & Dev, Manchester, Lancs, England
[10] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England
来源：
LANCET | 2020年 / 395卷 / 10223期
关键词：
EVENTS; TRIAL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：492 / 493
页数：3
相关论文
共 50 条
  • [1] Protective strategies to prevent trastuzumab-induced cardiotoxicity
    Guo, Shaohua
    Tse, Gary
    Liu, Tong
    LANCET, 2020, 395 (10223): : 491 - 492
  • [2] Trastuzumab-Induced Cardiotoxicity
    Stegall, Lisa
    Starbuck, Mandy Fields
    Mayer, Deborah K.
    Harwood, Elaine Brooks
    Glotzer, Jana
    ONCOLOGY NURSING FORUM, 2009, 36 (06) : 676 - 685
  • [3] Can Heart Failure Medications Prevent Trastuzumab-Induced Cardiotoxicity?
    Reynolds, Christopher C.
    Hartlage, Gregory
    Chen, Ren
    Patel, Vinod
    Guglin, Maya
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S80 - S80
  • [4] Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
    Milano, Gerard A.
    Serres, Emilie
    Ferrero, Jean-Marc
    Ciccolini, Joseph
    CURRENT DRUG TARGETS, 2014, 15 (13) : 1200 - 1204
  • [5] Trastuzumab-induced cardiotoxicity: Heart failure at the crossroads
    Sengupta, Partho P.
    Northfelt, Donald W.
    Gentile, Federico
    Zamorano, Jose L.
    Khandheria, Bijoy K.
    MAYO CLINIC PROCEEDINGS, 2008, 83 (02) : 197 - 203
  • [6] Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer
    Nicolazzi, M. A.
    Carnicelli, A.
    Fuorlo, M.
    Scaldaferri, A.
    Masetti, R.
    Landolfi, R.
    Favuzzi, A. M. R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 2175 - 2185
  • [7] Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study
    Yasmin Hamirani
    Ibrahim Fanous
    Christopher M. Kramer
    Andrew Wong
    Michael Salerno
    Patrick Dillon
    Medical Oncology, 2016, 33
  • [8] Upregulation of mitochondrial fusion as potential cardioprotective strategies against trastuzumab-induced cardiotoxicity in rats
    Maneechote, C.
    Khuanjing, T.
    Ongnok, B.
    Arinno, A.
    Prathumsap, N.
    Chunchai, T.
    Arunsak, B.
    Kerdphoo, S.
    Chattipakorn, S. C.
    Chattipakorn, N.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Troponin 1 elevation predicts trastuzumab-induced cardiotoxicity
    Reactions Weekly, 2010, 1320 (1) : 5 - 5
  • [10] Trastuzumab-Induced Cardiotoxicity: Is it Time for Troponin for all Patients?
    Ferte, Charles
    Massard, Christophe
    Cohen, Ariel
    Soria, Jean-Charles
    Ederhy, Stephane
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 183 - 184
12345